Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors

July 31, 2024

https://www.globenewswire.com/news-release/2024/07/31/2921727/0/en/Mural-Oncology-Appoints-Veteran-Business-Development-Executive-George-Golumbeski-Ph-D-to-its-Board-of-Directors.html

WALTHAM, Mass and DUBLIN, July 31, 2024 (GLOBE NEWSWIRE) — Mural Oncology plc (Nasdaq:MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced the appointment of George Golumbeski, Ph.D., to its board of directors effective July 30.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.